Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
glp-1 medications brands Eli Lilly pill Foundayo approved for obesity Weight gain Could GLP-1 drugs affect Color:Gunmetal
Could GLP-1 drugs affect risk of epilepsy for people with diabetes?
GLP-1 receptor agonists—medications such as semaglutide and liraglutide—have gained attention for their weight management properties, though they were originally developed for type 2 diabetes
Weight gain
Color:Gunmetal
LEADER (liraglutide) [44], SUSTAIN-6 (semaglutide) [67], and REWIND (dulaglutide) [70] study showed beneficial renal outcomes, mainly reducing the occurrence of proteinuria
![O-Ring BT80919-76076-71 [BT]](https://cdn.shopify.com/s/files/1/0362/6994/9068/files/png1_75b5c524-bfd0-45a5-a4c5-111d1d0944dd.png?v=1689121709)
